Correlation Between Novo Nordisk and ACELYRIN, INC
Can any of the company-specific risk be diversified away by investing in both Novo Nordisk and ACELYRIN, INC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novo Nordisk and ACELYRIN, INC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novo Nordisk AS and ACELYRIN, INC Common, you can compare the effects of market volatilities on Novo Nordisk and ACELYRIN, INC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novo Nordisk with a short position of ACELYRIN, INC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novo Nordisk and ACELYRIN, INC.
Diversification Opportunities for Novo Nordisk and ACELYRIN, INC
-0.44 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Novo and ACELYRIN, is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Novo Nordisk AS and ACELYRIN, INC Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ACELYRIN, INC Common and Novo Nordisk is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novo Nordisk AS are associated (or correlated) with ACELYRIN, INC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ACELYRIN, INC Common has no effect on the direction of Novo Nordisk i.e., Novo Nordisk and ACELYRIN, INC go up and down completely randomly.
Pair Corralation between Novo Nordisk and ACELYRIN, INC
Assuming the 90 days horizon Novo Nordisk AS is expected to generate 0.52 times more return on investment than ACELYRIN, INC. However, Novo Nordisk AS is 1.92 times less risky than ACELYRIN, INC. It trades about -0.14 of its potential returns per unit of risk. ACELYRIN, INC Common is currently generating about -0.25 per unit of risk. If you would invest 11,315 in Novo Nordisk AS on August 27, 2024 and sell it today you would lose (864.00) from holding Novo Nordisk AS or give up 7.64% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Novo Nordisk AS vs. ACELYRIN, INC Common
Performance |
| Timeline |
| Novo Nordisk AS |
| ACELYRIN, INC Common |
Novo Nordisk and ACELYRIN, INC Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Novo Nordisk and ACELYRIN, INC
The main advantage of trading using opposite Novo Nordisk and ACELYRIN, INC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novo Nordisk position performs unexpectedly, ACELYRIN, INC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ACELYRIN, INC will offset losses from the drop in ACELYRIN, INC's long position.| Novo Nordisk vs. Nuvalent | Novo Nordisk vs. Arcellx | Novo Nordisk vs. Vaxcyte | Novo Nordisk vs. Viridian Therapeutics |
| ACELYRIN, INC vs. Eldorado Gold Corp | ACELYRIN, INC vs. Jutal Offshore Oil | ACELYRIN, INC vs. Lincoln Electric Holdings | ACELYRIN, INC vs. Vera Bradley |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |